Therefore, we assume that high expression of PAI-1 and insufficient activity of MMP-9 and, for diabetic patients, VEGF may be one of the mechanisms of impaired angiogenic potential of ADSCs from patients with CAD and CAD+T2DM. This evidence concerns the gene VEGFA and coronary artery disorder.